title: Dielectric relaxation study on tramadol monohydrate and its hydrochloride salt.
abstract: Dielectric relaxation measurements as well as differential scanning calorimetry and X-ray diffraction investigations were performed on tramadol monohydrate and its hydrochloride salt. Examined samples do not crystallize during cooling and in consequence they reach the glassy state. In the case of the hydrochloride tramadol we are able to monitor alpha-relaxation process despite large contribution of dc conductivity to the loss spectra. It is the first such study on the salt of the drug. Up to now the dielectric spectroscopy has been regarded as useless in measuring such kind of API (active pharmaceutical ingredient). In this paper we also made some suggestions about the nature of the secondary relaxations in the amorphous tramadol monohydrate and its salt. The knowledge about the molecular mechanisms, which govern the observed secondary relaxations seems to be the key in predicting the stability of the amorphous form of the examined API. Finally additional dissolving measurements on the amorphous and crystal tramadol hydrochloride were performed. As a result we understood that dissolution properties of the amorphous form of the considered drug are comparable to those of crystalline one. However, we have found out that amorphous tramadol hydrochloride has greater ability to form tablets than its crystalline equivalent. This finding shows that amorphous drugs can be alternative even for the freely solved pharmaceuticals such as tramadol hydrochloride, because the former one has better ability to form tablets. It implies that during tabletting of the amorphous drugs there is no need to use any excipients and chemicals improving compaction properties of the API.
authors.affiliation: Institute of Physics, Silesian University, ul. Uniwersytecka 4, 40-007 Katowice, Poland. kaminski@us.edu.pl
authors.forename: K
authors.initials: K
authors.lastname: Kaminski
authors.forename: E
authors.initials: E
authors.lastname: Kaminska
authors.forename: K
authors.initials: K
authors.lastname: Adrjanowicz
authors.forename: K
authors.initials: K
authors.lastname: Grzybowiska
authors.forename: P
authors.initials: P
authors.lastname: Wlodarczyk
authors.forename: M
authors.initials: M
authors.lastname: Paluch
authors.forename: A
authors.initials: A
authors.lastname: Burian
authors.forename: J
authors.initials: J
authors.lastname: Ziolo
authors.forename: P
authors.initials: P
authors.lastname: Lepek
authors.forename: J
authors.initials: J
authors.lastname: Mazgalski
authors.forename: W
authors.initials: W
authors.lastname: Sawicki
mesh_terms: D000701:Analgesics, Opioid / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D004339:Drug Compounding; D004553:Electric Conductivity; D015394:Molecular Structure; D044367:Phase Transition; D012995:Solubility; D014147:Tramadol / Q000737:chemistry*; D014961:X-Ray Diffraction
chemical_list: D000701:Analgesics, Opioid; D014147:Tramadol